Clinical Trial Update: A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the safety of ONS-5010 when administered from vials versus pre-filled syringes in adults with retinal disorders causing visual impairm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Branch Retinal Vein Occlusion
• Diabetic Macular Edema

Drugs mentioned

• ONS-5010

Snippet

Sponsor: Outlook Therapeutics, Inc. | Conditions: Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration | Phase 3 | Status: ACTIVE_NOT_RECRUITING